Why It Matters

Montefiore Medical Center disclosed in its third-quarter 2026 lobbying report that it is monitoring implementation of the One Big Beautiful Bill Act, along with Medicare and Medicaid reimbursement, site-neutral payment policy, hospital transparency, the 340B drug-pricing program, National Institutes of Health (NIH) funding, congressionally directed funding, and Federal Emergency Management Agency (FEMA) reimbursement. Montefiore Medical Center is monitoring 340B drug pricing and site-neutral payment policy. The filing puts Montefiore formally on record across a broad range of enacted and pending federal health-payment changes affecting large urban academic medical centers. ​

By the Numbers

The third-quarter 2026 report, signed Oct. 20, lists $110,000 in lobbying expenditures. Montefiore Medical Center reported $110,000 in lobbying expenditures through Welsh Rose LLC in both its 2025 third-quarter and 2026 second-quarter filings.

Welsh Rose LLC is the sole registrant. The two lobbyists named on the filing are Founding Partners Kate Rose and Kristin Welsh. Rose served as a health legislative assistant in the Senate and a staff assistant in the House. Welsh served as a health policy adviser to the Senate Finance Committee from April to August 2015, during the 114th Congress.

Broader Context

H.R. 1, the One Big Beautiful Bill Act, was sponsored by Rep. Jodey C. Arrington (R-TX-19) and became Public Law 119-21 on July 4, 2025, modifying Medicaid, Medicare, private insurance, and rural providers. Montefiore's filing says it is monitoring implementation of the enacted law.

H.R. 3023, the Preventing Hospital Overbilling of Medicare Act, introduced April 24, 2025, would repeal certain exceptions to site-neutral payments for off-campus hospital outpatient departments; no Senate companion or later action is established. H.R. 267, the Health Care PRICE Transparency Act, introduced Jan. 3, 2025, addresses hospital and insurer price transparency and has no cosponsors on record.

The Bottom Line

Spending has been flat across all six quarters visible in the filing history, and the lobbying team has not changed; the one portfolio shift was the addition of the Disaster Planning/Emergencies code covering FEMA reimbursement, first appearing in the fourth quarter of 2025 and present in every subsequent quarter. The filing lists no specific legislation; it says only that Montefiore monitored issues related to 340B.

Advertisement

Access the Legis1 platform for comprehensive political news, data, and insights

Spot something wrong? Report an issue with this article